As of yesterday this biopharm stock gaped up approximately +47% and is currently stuck in a previous selling range established back in 2001. I believe there may be some interesting action at these levels given the strong gap up from $17 and into the $25 price level. These previously established levels between $25-$30 had sellers really come out evidenced by the...